Intuitive Surgical, Inc. (NASDAQ:ISRG) Holdings Boosted by Blue Fin Capital Inc.

Blue Fin Capital Inc. grew its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 13.6% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,597 shares of the medical equipment provider’s stock after purchasing an additional 191 shares during the period. Blue Fin Capital Inc.’s holdings in Intuitive Surgical were worth $834,000 as of its most recent SEC filing.

A number of other hedge funds also recently modified their holdings of the business. Connecticut Wealth Management LLC lifted its stake in Intuitive Surgical by 2.6% in the 4th quarter. Connecticut Wealth Management LLC now owns 1,053 shares of the medical equipment provider’s stock worth $549,000 after acquiring an additional 27 shares in the last quarter. Castleark Management LLC boosted its holdings in shares of Intuitive Surgical by 3.4% during the fourth quarter. Castleark Management LLC now owns 90,469 shares of the medical equipment provider’s stock worth $47,221,000 after purchasing an additional 2,990 shares during the period. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp grew its position in Intuitive Surgical by 15.0% during the fourth quarter. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp now owns 68,047 shares of the medical equipment provider’s stock valued at $35,518,000 after purchasing an additional 8,864 shares in the last quarter. PharVision Advisers LLC acquired a new position in Intuitive Surgical in the 4th quarter valued at approximately $676,000. Finally, Mpwm Advisory Solutions LLC purchased a new stake in Intuitive Surgical in the 4th quarter worth approximately $57,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts recently issued reports on ISRG shares. Bernstein Bank increased their price objective on Intuitive Surgical from $655.00 to $700.00 and gave the stock an “overweight” rating in a report on Monday, January 27th. Jefferies Financial Group lifted their price target on Intuitive Surgical from $475.00 to $575.00 in a report on Monday, January 27th. Robert W. Baird dropped their price objective on Intuitive Surgical from $600.00 to $575.00 and set an “outperform” rating on the stock in a report on Wednesday, April 23rd. Truist Financial reduced their target price on shares of Intuitive Surgical from $605.00 to $590.00 and set a “buy” rating for the company in a research note on Wednesday, April 23rd. Finally, Leerink Partners boosted their target price on shares of Intuitive Surgical from $490.00 to $548.00 in a research report on Monday, January 27th. Five research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $598.95.

Intuitive Surgical Price Performance

Shares of Intuitive Surgical stock opened at $547.07 on Thursday. The company has a market cap of $196.08 billion, a PE ratio of 85.35, a price-to-earnings-growth ratio of 5.85 and a beta of 1.70. The firm has a fifty day moving average price of $509.36 and a two-hundred day moving average price of $537.43. Intuitive Surgical, Inc. has a fifty-two week low of $396.15 and a fifty-two week high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, beating the consensus estimate of $1.71 by $0.10. Intuitive Surgical had a net margin of 27.81% and a return on equity of 14.55%. The business had revenue of $2.25 billion during the quarter, compared to analysts’ expectations of $2.19 billion. During the same quarter last year, the company earned $1.50 earnings per share. Analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Insiders Place Their Bets

In related news, CFO Jamie Samath sold 188 shares of the company’s stock in a transaction on Friday, February 28th. The stock was sold at an average price of $566.94, for a total value of $106,584.72. Following the completion of the transaction, the chief financial officer now directly owns 7,162 shares in the company, valued at approximately $4,060,424.28. This represents a 2.56% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Jami K. Nachtsheim sold 2,400 shares of the business’s stock in a transaction on Thursday, May 1st. The shares were sold at an average price of $520.00, for a total transaction of $1,248,000.00. Following the completion of the sale, the director now directly owns 6,371 shares in the company, valued at $3,312,920. This trade represents a 27.36% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 32,700 shares of company stock worth $16,865,621. 0.70% of the stock is currently owned by company insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.